Intelligence Profile
Clinical Applications
Based on the available evidence, there is limited specific information about "Cardiogen" as a clinical therapy. The evidence provided primarily relates to one completed clinical trial (NCT01424774) titled "Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning."
Clinical Applications
From the available trial information, Cardiogen appears to be related to CardioGen-82, which is used in cardiac positron emission tomography (PET) myocardial perfusion imaging (MPI). The completed study (NCT01424774) investigated strontium evaluation in patients who had undergone CardioGen-82 PET MPI scanning, suggesting this compound is used in cardiac imaging procedures.
CardioGen-82 is typically used for:
- Myocardial perfusion imaging to assess blood flow to the heart muscle
- Detection of coronary artery disease
- Evaluation of cardiac function
Limited Evidence Base
Important limitation: The evidence provided does not contain detailed clinical trial results or efficacy data specifically for Cardiogen. The PubMed findings focus on other cardiac conditions (transthyretin cardiac amyloidosis, dilated cardiomyopathy, heart failure) and different therapeutic approaches (vutrisiran, genetic counseling) that do not appear directly related to Cardiogen.
Without access to the actual results and findings from the completed trial NCT01424774, or additional clinical studies specifically evaluating Cardiogen's efficacy and safety profile, a comprehensive assessment of its clinical applications and outcomes cannot be provided.
Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Patients should consult with their healthcare providers for personalized treatment recommendations.